ArticleInvestigative ophthalmology & visual science2025
The Role of ARL13B in Mitochondrial Homeostasis in Cultured Human Corneal Endothelial Cells.
Article in Investigative ophthalmology & visual science, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Purpose: The purpose of this study was to investigate the relationship between primary cilia and mitochondrial function in cultured human corneal endothelial cells (HCECs). Methods: HCECs obtained from donor corneas were cultured and categorized into either differentiated cells or cell-state transition (CST) cells based on the expression of CD44, a non-kinase transmembrane glycoprotein. The frequency of primary cilia was then compared between the differentiated and CST cells using immunofluorescence. Expression of ADP-ribosylation factor-like protein 13B (ARL13B) was inhibited with small interfering RNA (siRNA) to assess the effects on key proteins and mitochondrial function following siRNA treatment via reverse-transcription quantitative polymerase chain reaction, immunofluorescence, and Seahorse XFe24 Extracellular Flux Analyzer (Agilent Technologies) findings. Results: Compared with the differentiated cells, the CST cells exhibited a higher frequency of primary cilia, a lower cell density, and larger nuclei. ARL13B knockdown significantly reduced alpha-tubulin messenger RNA (mRNA) expression, yet did not affect the frequency of primary cilia. On the other hand, ARL13B knockdown altered the localization of aquaporin-1 (AQP1) to the cell membrane and significantly increased mitochondrial oxidative phosphorylation (OXPHOS) without affecting glycolysis. Conclusions: The findings in this study highlight the importance of ARL13B in cultured HCECs and its impact on mitochondrial function and AQP1 localization. Although ARL13B knockdown did not affect the frequency of primary cilia, it significantly enhanced mitochondrial OXPHOS and led to a shift in AQP1 localization, thus suggesting a functional modulation of metabolism in cultured HCECs.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.